Page 115 - Tata_Chemicals_yearly-reports-2021-22

01 INTEGRATED 73 STATUTORY 178 FINANCIAL
REPORTS
REPORT
STATEMENTS
Management Discussion
& Analysis
(G) Total Debt and Amortisation Schedule
Decrease in finance cost in TCNA due to decrease in repricing/ Repayment schedule of existing debt
refinancing of loans. In TCML, part loan was prepaid during the
year leading to lower costs.
8,000 7,025 ` in crore
7,000
viii. Other expenses ` in crore 6,000 TCL consolidated
FY FY % 5,000
Entity Change 4,000 3,161
2021-22 2020-21 Change
3,000
TCL, India 460 461 (1) - 2,000 760 751 1,197 1,156
TCNA, USA 836 722 114 16 1,000
–
TCE Group, UK 354 321 33 10 Mar 2022 FY 2022-23 FY 2023-24 FY 2024-25 FY 2025-26 FY 2026-27
Gross Debt Repayment
TCML, Kenya 145 119 26 22
Rallis, India 396 347 49 14 Notes:
Others and
Eliminations 31 38 (7) (18) 1. Gross debt of ` 7,025 crore includes ` 236 crore of
working capital loans/current borrowings.
Total 2,222 2,008 214 11
2. The repayment schedule for term loans has been
Other expenses represent the following ` in crore prepared considering the existing repayment terms.
FY FY % Some of these loans/facilities may be refinanced in full
Particulars Change or in part from time to time in future depending on
2021-22 2020-21 Change
Stores and spares the requirement and the business plans. Non-current
portion of finance leases has been included in FY 2023-
consumed 314 279 35 13
24 repayment.
Packing materials
consumed 319 227 92 41 8. Innovation and Technology
Repairs 448 421 27 6 Innovation Centre
Rent 43 52 (9) (17) The Innovation Centre (‘IC’) at Pune is the Company’s
Royalty, rates and science and technology hub for seeding new businesses
taxes 378 283 95 34 and accelerating the Company’s businesses. IC supports the
Distributor’s service Company’s businesses by providing cutting-edge technology
charges and sales solutions and a customer-centric, multi-disciplinary problem-
promotion 79 84 (5) (6) solving approach for sustainable growth and differentiation.
Others* 641 662 (21) (3) The Company has 177 patents (cumulative) and over 100
Total 2,222 2,008 214 11 active applications. In FY 2021-22, IC published 4 research
papers in international peer-reviewed journals.
* Others include insurance charges, professional fees, foreign exchange loss,
travelling expense, provision for doubtful debts and advances, directors’ fees / During the year, IC significantly contributed to development
commission, subcontracting cost, outsourcing cost and other expenses. of application specific grades of silica for tyre, rubber and
textile applications and customised formulations using
(F) Details of significant changes in key Consolidated prebiotics (FOS) and development of Inulin. The Company
financial ratios: won the prestigious CII’s India’s top 25 Most Innovative
1. Net Profit Margin (%) of the Company has increased to 11% Companies in 2021 for the third time in a row, won 2
(FY 2020-21: 4%) due to overall improvement in volumes, awards at ISQ Quality Innovation Awards at National Level
revenue partly offset by higher costs across geography and is the only Indian Company to win at the International
(Previous year lower profit/revenue from operations due to Quality Innovation Awards. The Company received special
COVID-19 impact). appreciation award for its Intellectual Property (‘IP’) practices
and portfolio from CII as well.
2. Return on Net Worth (%) of the Company has increased to
8% (FY 2020-21: 3%) due to increase in improved operating 9. Digitalisation and Information Technology
performance across geography (Previous year lower profit/ The Company is looking at step improvements in its
revenue from operations due to COVID-19 impact)
manufacturing efficiencies, process efficiencies and

113